{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:05:22Z","timestamp":1769555122973,"version":"3.49.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.molmed.2009.10.004","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T12:51:00Z","timestamp":1257425460000},"page":"553-561","source":"Crossref","is-referenced-by-count":48,"title":["Pseudoviral immunity \u2013 a novel concept for lupus"],"prefix":"10.1016","volume":"15","author":[{"given":"Hans-Joachim","family":"Anders","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2009.10.004_bib1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2009.10.004_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/gene.2009.39","article-title":"Recent insights into the genetic basis of systemic lupus erythematosus","volume":"10","author":"Moser","year":"2009","journal-title":"Genes Immun."},{"key":"10.1016\/j.molmed.2009.10.004_bib3","doi-asserted-by":"crossref","first-page":"14875","DOI":"10.1073\/pnas.95.25.14875","article-title":"A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families","volume":"95","author":"Gaffney","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2009.10.004_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1600-065X.2007.00571.x","article-title":"Autoimmune diseases caused by defects in clearing dead cells and nuclei expelled from erythroid precursors","volume":"220","author":"Nagata","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molmed.2009.10.004_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.immunol.22.012703.104514","article-title":"Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease","volume":"25","author":"Marshak-Rothstein","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.gene.6364409","article-title":"A compass that points to lupus: genetic studies on type I interferon pathway","volume":"8","author":"Kyogoku","year":"2007","journal-title":"Genes Immun."},{"key":"10.1016\/j.molmed.2009.10.004_bib7","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1073\/pnas.0901181106","article-title":"Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus","volume":"106","author":"Jacob","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2009.10.004_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-065X.2008.00737.x","article-title":"Innate immunity to virus infection","volume":"227","author":"Takeuchi","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molmed.2009.10.004_bib9","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2009.10.004_bib10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.immunol.26.021607.090400","article-title":"The IRF family transcription factors in immunity and oncogenesis","volume":"26","author":"Tamura","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib11","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/ndt\/gfl336","article-title":"Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice","volume":"21","author":"Patole","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.molmed.2009.10.004_bib12","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/nm1140","article-title":"Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis","volume":"10","author":"Wang","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2009.10.004_bib13","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1371\/journal.ppat.0020053","article-title":"Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia","volume":"2","author":"Le Goffic","year":"2006","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2009.10.004_bib14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nature01889","article-title":"Identification of Lps2 as a key transducer of MyD88-independent TIR signalling","volume":"424","author":"Hoebe","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2009.10.004_bib15","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1126\/science.1093620","article-title":"Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8","volume":"303","author":"Heil","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.molmed.2009.10.004_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2008-04-151712","article-title":"Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology","volume":"113","author":"Baenziger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2009.10.004_bib17","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1073\/pnas.0400937101","article-title":"Recognition of single-stranded RNA viruses by Toll-like receptor 7","volume":"101","author":"Lund","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2009.10.004_bib18","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.4049\/jimmunol.180.9.5799","article-title":"Cutting edge: overlapping functions of TLR7 and TLR9 for innate defense against a herpesvirus infection","volume":"180","author":"Zucchini","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.immuni.2008.11.012","article-title":"Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing","volume":"30","author":"Town","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2009.10.004_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-065X.2007.00564.x","article-title":"Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses","volume":"220","author":"Zhang","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molmed.2009.10.004_bib21","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1073\/pnas.0403555101","article-title":"Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways","volume":"101","author":"Hochrein","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2009.10.004_bib22","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI33940","article-title":"Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection","volume":"118","author":"Samuelsson","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2009.10.004_bib23","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1073\/pnas.0400525101","article-title":"Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection","volume":"101","author":"Tabeta","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2009.10.004_bib24","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1126\/science.1158298","article-title":"Pyogenic bacterial infections in humans with MyD88 deficiency","volume":"321","author":"von Bernuth","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.molmed.2009.10.004_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature06013","article-title":"DAI (DLM-1\/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response","volume":"448","author":"Takaoka","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2009.10.004_bib26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature07725","article-title":"AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC","volume":"458","author":"Hornung","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2009.10.004_bib27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nm1590","article-title":"TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity","volume":"13","author":"Baccala","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2009.10.004_bib28","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.cell.2009.06.015","article-title":"RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway","volume":"138","author":"Chiu","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2009.10.004_bib29","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ni.1779","article-title":"RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate","volume":"10","author":"Ablasser","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib30","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.4049\/jimmunol.170.7.3614","article-title":"The molecular basis for the lack of immunostimulatory activity of vertebrate DNA","volume":"170","author":"Stacey","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Kariko","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2009.10.004_bib32","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1096\/fasebj.13.11.1415","article-title":"Abnormal DNA methylation and deoxycytosine\u2013deoxyguanine content in nucleosomes from lymphocytes undergoing apoptosis","volume":"13","author":"Huck","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.molmed.2009.10.004_bib33","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.autrev.2005.02.003","article-title":"Apoptotic modifications affect the autoreactivity of the U1 snRNP autoantigen","volume":"4","author":"Hof","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.molmed.2009.10.004_bib34","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/art.1780331109","article-title":"Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis","volume":"33","author":"Richardson","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molmed.2009.10.004_bib35","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.4049\/jimmunol.140.7.2197","article-title":"Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity","volume":"140","author":"Cornacchia","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","article-title":"The many roles of FAS receptor signaling in the immune system","volume":"30","author":"Strasser","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2009.10.004_bib37","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/9544","article-title":"Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity","volume":"5","author":"Bickerstaff","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2009.10.004_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/ddh021","article-title":"Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus","volume":"13","author":"Russell","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2009.10.004_bib39","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/08916930701510673","article-title":"Complement deficiencies and systemic lupus erythematosus","volume":"40","author":"Truedsson","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.molmed.2009.10.004_bib40","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1126\/science.1094359","article-title":"Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice","volume":"304","author":"Hanayama","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.molmed.2009.10.004_bib41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/76032","article-title":"Features of systemic lupus erythematosus in Dnase1-deficient mice","volume":"25","author":"Napirei","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2009.10.004_bib42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/91070","article-title":"Mutation of DNASE1 in people with systemic lupus erythematosus","volume":"28","author":"Yasutomo","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2009.10.004_bib43","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1086\/513443","article-title":"Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi\u2013Goutieres syndrome","volume":"80","author":"Rice","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2009.10.004_bib44","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/eji.200838478","article-title":"Molecular mimicry in innate immunity? The viral RNA recognition receptor TLR7 accelerates murine lupus","volume":"38","author":"Anders","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib45","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1182\/blood-2005-07-2650","article-title":"U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7","volume":"107","author":"Savarese","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2009.10.004_bib46","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1084\/jem.20050914","article-title":"Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus","volume":"202","author":"Barrat","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2009.10.004_bib47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","article-title":"Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus","volume":"25","author":"Christensen","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2009.10.004_bib48","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/art.23407","article-title":"Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis","volume":"58","author":"Savarese","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molmed.2009.10.004_bib49","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.1124978","article-title":"Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication","volume":"312","author":"Pisitkun","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.molmed.2009.10.004_bib50","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.4049\/jimmunol.177.4.2088","article-title":"TLR7 ligands induce higher IFN-alpha production in females","volume":"177","author":"Berghofer","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib51","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/416603a","article-title":"Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors","volume":"416","author":"Leadbetter","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2009.10.004_bib52","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI23025","article-title":"Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9","volume":"115","author":"Means","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2009.10.004_bib53","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/ar2710","article-title":"DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Faslpr\/lpr mice in vivo","volume":"11","author":"Lenert","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.molmed.2009.10.004_bib54","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1681\/ASN.2005060658","article-title":"G-rich DNA suppresses systemic lupus","volume":"16","author":"Patole","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2009.10.004_bib55","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/art.20810","article-title":"Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB\u00d7NZW mice","volume":"52","author":"Dong","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molmed.2009.10.004_bib56","doi-asserted-by":"crossref","first-page":"37427","DOI":"10.1074\/jbc.M605311200","article-title":"The functional effects of physical interactions among Toll-like receptors 7, 8, and 9","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2009.10.004_bib57","doi-asserted-by":"crossref","first-page":"12542","DOI":"10.1074\/jbc.M310175200","article-title":"mRNA is an endogenous ligand for Toll-like receptor 3","volume":"279","author":"Kariko","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2009.10.004_bib58","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1084\/jem.20050338","article-title":"Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus","volume":"202","author":"Christensen","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2009.10.004_bib59","doi-asserted-by":"crossref","first-page":"F867","DOI":"10.1152\/ajprenal.90213.2008","article-title":"Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2\/Myd88 rather than Tlr3\/Trif","volume":"296","author":"Lichtnekert","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.molmed.2009.10.004_bib60","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.immunol.23.021704.115843","article-title":"Type I interferons (alpha\/beta) in immunity and autoimmunity","volume":"23","author":"Theofilopoulos","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib61","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib62","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.gene.6363966","article-title":"Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray","volume":"4","author":"Han","year":"2003","journal-title":"Genes Immun."},{"key":"10.1016\/j.molmed.2009.10.004_bib63","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1126\/science.1064890","article-title":"Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus","volume":"294","author":"Blanco","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.molmed.2009.10.004_bib64","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/BOR.0b013e32832e089e","article-title":"Type I interferon and lupus","volume":"21","author":"Ronnblom","year":"2009","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.molmed.2009.10.004_bib65","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1002\/art.23023","article-title":"Deficiency of the type I interferon receptor protects mice from experimental lupus","volume":"56","author":"Nacionales","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molmed.2009.10.004_bib66","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1084\/jem.20021996","article-title":"Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice","volume":"197","author":"Santiago-Raber","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2009.10.004_bib67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0896-8411(02)00109-9","article-title":"Type I interferon controls the onset and severity of autoimmune manifestations in lpr mice","volume":"20","author":"Braun","year":"2003","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.molmed.2009.10.004_bib68","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.4049\/jimmunol.173.3.2134","article-title":"Type I IFN protects against murine lupus","volume":"173","author":"Hron","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib69","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1681\/ASN.2004111014","article-title":"Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice","volume":"16","author":"Schwarting","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2009.10.004_bib70","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/sj.gene.6364421","article-title":"Genomic view of IFN-alpha response in pre-autoimmune NZB\/W and MRL\/lpr mice","volume":"8","author":"Lu","year":"2007","journal-title":"Genes Immun."},{"key":"10.1016\/j.molmed.2009.10.004_bib71","first-page":"638","article-title":"Tubuloreticular inclusions in peripheral blood mononuclear cells related to systemic therapy with alpha-interferon","volume":"52","author":"Grimley","year":"1985","journal-title":"Lab. Invest."},{"key":"10.1016\/j.molmed.2009.10.004_bib72","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM198909073211001","article-title":"Renal disease in children with the acquired immunodeficiency syndrome","volume":"321","author":"Strauss","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2009.10.004_bib73","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1126\/science.6166984","article-title":"Human lupus inclusions and interferon","volume":"213","author":"Rich","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.molmed.2009.10.004_bib74","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1093\/ndt\/gfp288","article-title":"The clinicopathological implications of endothelial tubuloreticular inclusions found in glomeruli having histopathology of idiopathic membranous nephropathy","volume":"24","author":"Yang","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.molmed.2009.10.004_bib75","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1172\/JCI200419139","article-title":"Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli","volume":"113","author":"Peterson","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2009.10.004_bib76","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1074-7613(01)00196-0","article-title":"Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus","volume":"15","author":"Rozzo","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2009.10.004_bib77","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/sj.ki.5002436","article-title":"Innate pathogen recognition in the kidney: toll-like receptors, NOD-like receptors, and RIG-like helicases","volume":"72","author":"Anders","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2009.10.004_bib78","doi-asserted-by":"crossref","unstructured":"Fl\u00fcr K, Allam R, Zecher D, Kulkarni OP, Lichtnekert J, Schwarz M, Beutler B, Vielhauer V, Anders HJ. (2009) Viral RNA induces type I interferon-dependent cytokine release and cell death in mesangial cells via melanoma-differentiation-associated gene-5. Implications for viral infection-associated glomerulonephritis. Am. J. Pathol. [Epub ahead of print]","DOI":"10.2353\/ajpath.2009.080585"},{"key":"10.1016\/j.molmed.2009.10.004_bib79","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1681\/ASN.2008101067","article-title":"Viral RNA and DNA sense common antiviral responses including type I interferons in mesangial cells","volume":"20","author":"Allam","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2009.10.004_bib80","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1093\/ndt\/gfp339","article-title":"Double-stranded RNA activates type I interferon secretion in glomerular endothelial cells via retinoic acid-inducible gene (RIG)-1","volume":"24","author":"Hagele","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.molmed.2009.10.004_bib81","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.it.2009.06.001","article-title":"TIR8\/SIGIRR: an IL-1R\/TLR family member with regulatory functions in inflammation and T cell polarization","volume":"30","author":"Garlanda","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib82","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/sj.ki.5002293","article-title":"Different roles of TiR8\/Sigirr on toll-like receptor signaling in intrarenal antigen-presenting cells and tubular epithelial cells","volume":"72","author":"Lech","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2009.10.004_bib83","doi-asserted-by":"crossref","first-page":"548","DOI":"10.4049\/jimmunol.177.1.548","article-title":"SIGIRR promotes resistance against Pseudomonas aeruginosa keratitis by down-regulating type-1 immunity and IL-1R1 and TLR4 signaling","volume":"177","author":"Huang","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib84","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.4049\/jimmunol.179.5.3119","article-title":"Damping excessive inflammation and tissue damage in Mycobacterium tuberculosis infection by Toll IL-1 receptor 8\/single Ig IL-1-related receptor, a negative regulator of IL-1\/TLR signaling","volume":"179","author":"Garlanda","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib85","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ni968","article-title":"SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling","volume":"4","author":"Wald","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib86","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1084\/jem.20072646","article-title":"Tir8\/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens","volume":"205","author":"Lech","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2009.10.004_bib87","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.immuni.2008.06.004","article-title":"When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction","volume":"29","author":"O\u2019Neill","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2009.10.004_bib88","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1084\/jem.20090585","article-title":"Loss of the lupus autoantigen Ro52\/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway","volume":"206","author":"Espinosa","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2009.10.004_bib89","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/ni.1771","article-title":"TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis","volume":"10","author":"Kawagoe","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib90","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2358","article-title":"Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases","volume":"8","author":"Gilliet","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib91","doi-asserted-by":"crossref","first-page":"8086","DOI":"10.1074\/jbc.M410868200","article-title":"Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-alpha induction by CpG-A in plasmacytoid dendritic cells","volume":"280","author":"Kerkmann","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2009.10.004_bib92","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1084\/jem.20031942","article-title":"Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes","volume":"199","author":"Boule","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2009.10.004_bib93","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0896-8411(02)00110-5","article-title":"Autoimmunity to nucleosomes related to viral infection: a focus on hapten-carrier complex formation","volume":"20","author":"Van Ghelue","year":"2003","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.molmed.2009.10.004_bib94","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1084\/jem.20051696","article-title":"Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8","volume":"202","author":"Vollmer","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2009.10.004_bib95","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1681\/ASN.2006101162","article-title":"Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus","volume":"18","author":"Pawar","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2009.10.004_bib96","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1002\/eji.200737815","article-title":"Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms","volume":"37","author":"Barrat","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molmed.2009.10.004_bib97","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/art.24557","article-title":"Neutralization of interferon-alpha\/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus","volume":"60","author":"Yao","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molmed.2009.10.004_bib98","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ni1146","article-title":"Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA","volume":"6","author":"Yoshida","year":"2005","journal-title":"Nat. Immunol."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491409001713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491409001713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T11:52:58Z","timestamp":1685188378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491409001713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":98,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1471491409001713"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2009.10.004","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}